Description and Brand Names
US Brand Name
Adalimumab-bwwd injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis. It is used in children 2 years of age and older for juvenile idiopathic arthritis. This medicine is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-bwwd may be used alone or in combination with other medicines (eg, methotrexate).
Adalimumab-bwwd injection is also used to treat moderate to severe active Crohn's disease. It is also used to treat moderate to severe ulcerative colitis.
Adalimumab-bwwd injection is also used to treat moderate to severe chronic plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).
This medicine is available only with your doctor's prescription.
Portions of this document last updated: May 01, 2023
版权 © 2023 IBM Watson Health。保留所有权利。信息仅供终端用户使用，不得出售、重新分发或用于其他商业目的。